Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Han

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
AAPS Pharmsci|December 14, 2001
Targeted prodrug design to optimize drug deliveryH K Han, G L Amidon
Pharmaceutical Biotechnology|April 1, 2000
Drug transport and targeting. Intestinal transportD M Oh, H K Han, G L Amidon
Journal of Cataract and Refractive Surgery|May 1, 1997
Computer-assisted videokeratography to measure changes in astigmatism induced by sutureless cataract surgeryC K Joo, H K Han, J H Kim
Pharmaceutical Research|October 2, 1998
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporterH K Han, D M Oh, G L Amidon
The International Journal of Adult Orthodontics and Orthognathic Surgery|April 20, 2001
Cephalometric characteristics of Korean Class III surgical patients and their relationship to plans for surgical treatmentH S Baik, H K Han, D J Kim, et al.
The Journal of Parasitology|April 29, 1999
Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvumJ Y Chai, S M Guk, H K Han, et al.
Life Sciences|November 7, 1998
In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonistsH K Han, B H Stewart, A M Doherty, et al.
Journal of Pharmaceutical Sciences|March 3, 1999
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugsH K Han, J K Rhie, D M Oh, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|January 1, 1987
Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemiaL T Ho, S H Li, T Y Chou, et al.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
AAPS Pharmsci|December 14, 2001
Targeted prodrug design to optimize drug deliveryH K Han, G L Amidon
Pharmaceutical Biotechnology|April 1, 2000
Drug transport and targeting. Intestinal transportD M Oh, H K Han, G L Amidon
Journal of Cataract and Refractive Surgery|May 1, 1997
Computer-assisted videokeratography to measure changes in astigmatism induced by sutureless cataract surgeryC K Joo, H K Han, J H Kim
Pharmaceutical Research|October 2, 1998
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporterH K Han, D M Oh, G L Amidon
The International Journal of Adult Orthodontics and Orthognathic Surgery|April 20, 2001
Cephalometric characteristics of Korean Class III surgical patients and their relationship to plans for surgical treatmentH S Baik, H K Han, D J Kim, et al.
The Journal of Parasitology|April 29, 1999
Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvumJ Y Chai, S M Guk, H K Han, et al.
Life Sciences|November 7, 1998
In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonistsH K Han, B H Stewart, A M Doherty, et al.
Journal of Pharmaceutical Sciences|March 3, 1999
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugsH K Han, J K Rhie, D M Oh, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|January 1, 1987
Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemiaL T Ho, S H Li, T Y Chou, et al.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Pageof 1